Taro Pharmaceutical Industries Ltd expected to post earnings of 30 cents a share - Earnings Preview

Taro Pharmaceutical Industries

23/01/2024 21:27

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a rise in quarterly revenue when it reports  results on
January 25 for the period ending December 31 2023
    * The Haifa Israel-based   company is expected to report a
11.3% increase in revenue to $154.907 million from $139.2
million a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Taro Pharmaceutical
Industries
Ltd is for earnings of 30 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $43.00​, above​ its last
closing price of $42.27. ​​​

This summary was machine generated January 23 at 21:26 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)